Home
Live Updates
FDA moves closer to sickle cell cure that uses gene editing : comparemela.com
FDA moves closer to sickle cell cure that uses gene editing
The FDA is one step closer to approving a cure for sickle cell disease that uses CRISPR gene editing. It would be the first approve drug to use gene editing.
Related Keywords
Philadelphia ,
Pennsylvania ,
United States ,
Virginia ,
Biree Andemariam ,
Scot Wolfe ,
Lisa Lee ,
Joseph Wu ,
Stephan Grupp ,
Umass Chan Medical School ,
Virginia Polytechnic Institute ,
Institute For Clinical ,
England Sickle Cell Institute ,
University Of Connecticut ,
Vertex Pharmaceuticals ,
Centers For Disease ,
Drug Administration ,
Stanford Cardiovascular Institute ,
Disease Control ,
New England Sickle Cell Institute ,
Chan Medical ,
Stanford Cardiovascular ,
Economic Review ,
Sickle Cell Disease ,
Red Blood Cells ,
Food And Drug Administration ,
Blood Cells ,
Committee Member ,
Crispr Therapeutics ,
comparemela.com © 2020. All Rights Reserved.